On Mar. 10, 2020, the Secretary of Health and Human Services (HHS) invoked the 2005 Public Readiness and Emergency Preparedness (PREP) Act, after declaring that the COVID-19 pandemic was a public health emergency. As a result, manufacturers of COVID-19 vaccines that have been developed to respond to the SARS-CoV-2 pandemic are considered public health emergency “countermeasures”. The PREP Act shields manufacturers and vaccine providers from liability and vaccine injury compensation claims will be processed by the Countermeasures Injury Compensation Program (CICP).
All COVID-19 vaccines, including the licensed Pfizer and Moderna mRNA COVID-19 vaccines, are considered countermeasures. Persons harmed or who die as a result of vaccination may file for benefits through the CICP within one year of injury or death of a loved one.
As of December 1, 2024, HRSA reports that 10,473 claims alleging injury or death following COVID-19 vaccines have been filed with the CICP. Additionally, 3,082 claims alleging injury or death following additional COVID-19 countermeasures (i.e. medications, treatments, testing) have also been filled. Of the 3,497 claims where HRSA has rendered a decision, only 65 claims were found to be eligible for compensation. Twenty claims have been compensated (thirteen for myocarditis, three for myopericarditis, two for syncope, one for Guillain-Barre Syndrome, and one for anaphylaxis following COVID-19 vaccination), 44 claims are pending a determination of benefits, and one claim has been found to have no eligible reported expenses. The CICP has paid out a total of $448,665.86 for claims associated with COVID-19 vaccines as of December 1, 2024.
HRSA has denied 3,432 claims, with 2,075 denied for missing the one-year filing deadline, 606 denied for non-receipt of medical records, 255 denied due to product considered ineligible for CICP benefits or due to non-specified reasons, and 496 claims denied due to the “standard of proof not met and/or covered injury not sustained.”
IMPORTANT NOTE: NVIC encourages you to become fully informed about COVID-19 and the COVID-19 vaccine by reading all sections in the table of contents, which contains many links and resources such as the manufacturer product information inserts, and to speak with one or more trusted health care professionals before making a vaccination decision for yourself or your child. This information is for educational purposes only and is not intended as medical advice.